EULAR Advocacy Committee

The EULAR Advocacy Committee engages with the EU as well as other national political institutions as a recognised partner and source of expertise in rheumatic and musculoskeletal diseases. The Committee fights for the recognition of the needs of people with rheumatic and musculoskeletal diseases (RMDs) by advocating research and education in rheumatology, promoting the EULAR brand as a reliable source of information, coordinating the work of the Sub-Committee(s) (Communication), and providing strategic guidance on all EULAR messages to internal and external audiences.

Advocacy Committee By-Laws

Communications Sub-Committee Regulations


Chair: Prof. Margreet Kloppenburg, Netherlands  
Chair-Elect: 
Dr. Elena Nikiphorou, United Kingdom
EMA Liaison: Prof. Marta Mosca, Italy
BioMed Alliance Liaison: Prof. Annamaria Iagnocco, Italy
 

Advisors: Dr. Rikke Helene Moe, Norway & Prof. Annamaria Iagnocco, Italy
Consultants: Rory Douglas Home, UK/Belgium & Frans Green, UK/Belgium

 
 
 Committee Members
Katy Antonopoulou, Greece
Mandate duration: Jun-25 – Jun-29

Carina Bostrom, Sweden
Mandate duration: Jun-25 – Jun-29

Sina Bugeja, Malta
Mandate duration: Jun-23 – Jun-27

Nele Caeyers, Belgium
Mandate duration: Jun-25 – Jun-29

Francisco Xavier Carreira Roca, Spain
Mandate duration: Jun-25 – Jun-29

Rory Douglas Home, United Kingdom
Mandate duration: from Jun-21

Zineb Ez-Zaitouni, Netherlands
Mandate duration: Jun-23 – Jun-27

Ricardo Ferreira, Portugal
Mandate duration: Jun-23 – Jun-27

Ruth Fritsch-Stork, Austria
Mandate duration: Jun-25 – Jun-29

Oliver Hendricks, Denmark
Mandate duration: Jun-23 – Jun-27

Razvan Ionescu, Romania
Mandate duration: Jun-23 – Jun-27

Pia Isomaki, Finland
Mandate duration: Jun-23 – Jun-27

Margreet Kloppenburg, Netherlands
Mandate duration: Jun-23 – Jun-27

Sandra Meisalu, Estonia
Mandate duration: Jun-25 – Jun-29

Xabier Michelena Vegas, Spain
Mandate duration: Jun-23 – Jun-27

Rikke Moe, Norway
Mandate duration: from Jun-25

Elena Nikiphorou, United Kingdom
Mandate duration: Jun-25 – Jun-29

Philipp Sewerin, Germany
Mandate duration: Jun-23 – Jun-27

Gian Domenico Sebastiani, Italy
Mandate duration: Jun-25 – Jun-29

Zoltan Szekanecz, Hungary
Mandate duration: Jun-23 – Jun-27

Thea Vliet-Vlieland, Netherlands
Mandate duration: Jun-23 – Jun-27

Jelena Vojinovic, Serbia
Mandate duration: Jun-23 – Jun-27

Anna Voormann, Germany
Mandate duration: Jun-25 – Jun-29

Anthony Woolf, United Kingdom
Mandate duration: Jun-25 – Jun-29


Related Information
EULAR Advocacy Newsletter 

EULAR is committed to bringing rheumatic and musculoskeletal diseases (RMDs) onto the EU's agenda. Sign up to the EULAR Advocacy newsletter to keep up with the changes that our organisation is working towards in the area of policy and legislation to help achieve better social and economic outcomes for the many millions of people affected by these chronic and debilitating diseases across Europe.

 Subscribe now


EULAR Project Proposals

All EULAR project proposals are to be submitted by 15 January or 01 July of each year and is subject to the approval of the EULAR Council. The final decision and budget of a project will be determined by the EULAR Council each March and September.
Download the EULAR Project Proposal template
Submit your proposal to:
eular@eular.org


About EULAR Advocacy

EU Advocacy is a key activity for a European umbrella organisation like the European Alliance of Associations for Rheumatology (EULAR).

See more


EULAR Advocacy Partnerships

EULAR is committed to partner with organisations and scientific medical societies at a EU and national level towards improving research funding, social policy legislation and quality of care; assisting advocacy actions on the national and international levels around rheumatic and musculoskeletal diseases (RMDs).

See more


EULAR Advocacy Activities and Materials

In order to persuade governmental and EU key decision-makers supporting the European rheumatology community, EULAR Advocacy develops evidence-based materials about RMDs and communicates its position on key policies and legislation being discussed.

See more


EULAR Policy Statements

As part of its advocacy activities, EULAR produces and adopts a number of documents and declarations that are used to express EULAR’s position and/or demands on different policy issues.

See more


EU Parliament Interest Group on RMDs

The European Parliament Interest Group on Rheumatic and Musculoskeletal Diseases (RMDs) was created in 2009 on the occasion of World Arthritis Day (12 October) and was re-established during the current parliamentary term (2014-2019).

See more


Links to Other Organisations

Partnerships that help to increase the knowledge of the organisations involved and the impact they can have on the political stage.

See more


RMD Definition

EULAR description on Rheumatic and Musculoskeletal Diseases (RMDs)

See more


EULAR Statutes, Reports, and By-Laws

The official statutes of the European Alliance of Associations for Rheumatology, EULAR

See more


EULAR Committees

Established by the Board, Committees are set up to manage and perform the various activities of EULAR on behalf of the Council.

See more